|
KMID : 1151620160010020074
|
|
Journal of Retina
2016 Volume.1 No. 2 p.74 ~ p.78
|
|
|
Intravitreal Bevacizumab Injection for Choroidal Neovascularization Associated with Multifocal Choroiditis
|
|
Cho In-Hwan
Park Un-Chul
Yu Hyeong-Gon
|
|
|
Abstract
|
|
|
Purpose: To evaluate the long-term efficacy and safety of intravitreal bevacizumab injections for choroidal neovascularization (CNV) associated with multifocal choroiditis (MFC).
Methods: This is a retrospective case series study. Patients who were treated with intravitreal bevacizumab injections for CNV associated with MFC from January 2004 to August 2016 were included. The characteristics of patients, change in best corrected visual acuity, and central subfield thickness (CST) were reviewed.
Results: Among 34 MFC eyes (22 patients), 6 eyes (6 patients, 17.6%) had CNV associated with MFC. The mean age of patients was 41 (26-64) years and four of six patients (66%) were female. The mean duration of follow-up was 101.5 (36-178) months and the mean number (range) of intravitreal bevacizumab injections was 2.3 (1-6). Three of six (50%) eyes showed evident inflammation and were treated with immunosuppression agents. Visual acuity improved in five of six (83%) eyes and CST decreased in all eyes at final visit. One eye with initial poor visual acuity (2/100) continued to have poor final visual acuity (2/100) with scar changes. No adverse events were reported.
Conclusions: Intravitreal bevacizumab injections were safe and effective at improving visual acuity and decreasing CST over long-term follow-up in a small series of patients with CNV secondary to MFC.
|
|
|
KEYWORD
|
|
|
Bevacizumab, Choroidal neovascularization, Multifocal choroiditis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|